A PYMNTS Company

US/EU: Healthcare co Baxter sends secret concessions to EC for dialysis merger

By  |  July 7, 2013

As US-based healthcare company Baxter awaits antitrust approval for its buyout of Sweden-based dialysis company Gambro, Baxter reportedly sent concessions to the European Commission to quell competition concerns over the deal within the EU, though terms of that offer were not disclosed. Reports say Baxter has yet to hear rulings on the merger within China, Australia and Ukraine, valued at $4 billion. The deal was first announced in 2012.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Full Content: Mass Device

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.